Median Arcuate Ligament Syndrome (MALS): Comprehensive Clinical Update for Healthcare Professionals

Definition and Pathophysiology

Median Arcuate Ligament Syndrome (MALS), also known as celiac artery compression syndrome or superior mesenteric artery (SMA)–aorta compression variant, is a rare, mechanically mediated vascular disorder characterized by dynamic compression of the celiac trunk (and often adjacent structures) by the median arcuate ligament (MAL)—a fibromuscular band connecting the right and left crura of the diaphragm across the anterior aspect of the aortic hiatus at the level of T12.

While historically described as compression only of the celiac artery, modern imaging and pathophysiological understanding confirm that MALS involves multimodal compression:

  • Vascular: Compression of the celiac trunk (in 85–95% of cases), sometimes extending into the left gastric or splenic arteries. Flow obstruction is often dynamic, worsening during expiration (when diaphragm ascends and ligament tightens) and improving with deep inspiration.
  • Neurogenic: Compression of the celiac plexus—a dense network of autonomic nerves surrounding the aortic origin of the celiac trunk—contributing to visceral pain, dysmotility, and nausea independent of hemodynamic compromise (Rochkind et al., World J Gastroenterol, 2014; Cools et al., Eur J Vasc Endovasc Surg, 2018).
  • Functional consequence: Chronic ischemia/reperfusion injury to upper GI organs (stomach, liver, spleen, pancreas) may induce neuronal sensitization, mitochondrial dysfunction, and central sensitization—explaining persistent symptoms even after anatomical decompression in some patients.

Epidemiology & Clinical Suspicion

MALS predominantly affects thin, young-to-middle-aged adults (mean age 30–50 years), with a strong female predominance (F:M ≈ 4:1) (Choudhary et al., Ann Vasc Surg, 2021). It is often misdiagnosed as functional dyspepsia or gastroparesis. A high index of suspicion is required in patients presenting with:

  • Postprandial epigastric pain (typically 15–60 minutes after eating), severe enough to cause food fear and voluntary caloric restriction
  • Refractory weight loss (often >10% body weight over 6–12 months)
  • Vomiting of undigested food, bloating, early satiety

Notably, many patients report worsening with upright posture or expiration, and symptom relief when leaning forward or lying recumbent—a clue to mechanical causation (Firpi et al., J Vasc Surg, 2010).


Symptom Profile: Beyond Classic Triad

While the classic triad—postprandial pain, weight loss, epigastric bruit—is taught, recent cohort studies reveal a broader phenotypic spectrum (Zhou et al., JAMA Surg, 2023 meta-analysis):

CategorySymptoms & Features
GI MotilityDelayed gastric emptying (confirmed via scintigraphy in >70% of cases), gastroparesis-like symptoms, constipation-predominant or alternating bowel habits
VascularEpigastric bruit (present in ~60–85%; often diastolic or continuous; loudest over epigastrium during expiration)
Autonomic/NonspecificDizziness/syncope (especially postprandial), exercise intolerance, fatigue, anxiety/depression (partly secondary to chronic illness, partly neurogenic)
Red Flags for MisdiagnosisAbsence of chronic symptoms (<3 months) strongly argues against MALS; presence of heartburn/GERD symptoms may indicate concomitant hiatal hernia or eosinophilic esophagitis

Diagnostic Workup: Evidence-Based Algorithm

A stepwise diagnostic approach is essential to exclude organic mimics (e.g., gastric cancer, pancreatic mass, chronic mesenteric ischemia) and confirm hemodynamically significant compression.

  1. Initial Screening
    • Laboratory tests: Rule out malnutrition/malabsorption—low albumin, prealbumin, iron, B12, fat-soluble vitamins (A/D/E/K); elevated triglycerides postprandially (suggestive of impaired chylomicron clearance) (Rochkind et al., 2014).
    • Abdominal Doppler ultrasound (US): First-line imaging. Key findings:
      • Peak systolic velocity (PSV) >200 cm/s at celiac origin (indicating stenosis)
      • Respiratory variability: PSV decreases ≥30% during inspiration vs expiration (specificity >90%) (Kwon et al., J Ultrasound Med, 2020).
      • Postprandial flow augmentation failure—absent or blunted increase in celiac flow after standardized meal.
  2. Confirmatory Imaging (Anatomical + Hemodynamic)
    • CT angiography (CTA): Gold standard for anatomy. Essential requirements:
      • Multi-phase acquisition (arterial, portal venous, delayed)
      • Respiratory gating or breath-hold comparison to assess dynamic compression
      • Stenosis >70% with post-stenotic dilatation and delayed filling of celiac branches supports diagnosis (Choudhary et al., 2021).
    • MR angiography (MRA): Avoids radiation/iodinated contrast. Steady-state free precession (SSFP) sequences capture respiratory motion. Limitations: lower spatial resolution, overestimation of stenosis.
    • Conventional angiography with phasic flow studies: Reserved for equivocal cases or when endovascular intervention is planned. Dynamic cine-angiography during forced expiration vs inspiration remains the most sensitive test for dynamic compression (sensitivity 95%, specificity 85–90%) (Firpi et al., 2010).
  3. Functional Assessment
    • Solid-phase gastric emptying scintigraphy: Confirms delayed emptying (lag phase >10 min, retention >60% at 90 min). Note: Delayed emptying alone is insufficient for MALS diagnosis—must correlate with imaging findings.
    • Celiac plexus blockade (diagnostic & therapeutic): Ultrasound- or CT-guided injection of local anesthetic ± steroid. >50% pain reduction at 24h strongly supports neurogenic component and predicts surgical response (Liu et al., Pain Med, 2022).

Treatment Strategies: Integrating Evidence

1. Medical Management (First-line, but limited efficacy)

  • Nutritional support: High-calorie liquid supplements, small frequent meals, avoid large/fatty meals.
  • Prokinetics: Domperidone or erythromycin for gastroparesis (limited evidence in MALS-specific populations).
  • Pain control: Avoid opioids (worsen motility); consider gabapentin/pregabalin for neuropathic component.

2. Interventional Procedures

  • Celiac plexus neurolysis (CPN): Ethanol or phenol injection under CT/US guidance.
    • Short-term analgesia: >80% pain relief at 1 month (Liu et al., 2022).
    • Limitation: Temporary effect (3–6 months); does not address vascular compression.

3. Surgical Management (Definitive Therapy for Symptomatic Cases)

  • Indications: Recalcitrant postprandial pain, weight loss >10% ideal body weight, abnormal gastric emptying plus imaging-confirmed compression.
  • Procedure:
    • Laparoscopic decompression: Current standard of care. Involves:
      1. Division of MAL fibers over the celiac trunk
      2. Mobilization of the ligament from aortic wall
      3. Optional: Resection of entrapped celiac plexus (controversial; may improve pain outcomes)
      • Key technical tip: Preserve the retroaortic space to avoid lymphatic injury and chyle leak (Cools et al., 2018).
    • Open decompression: Reserved for complex anatomy, prior surgery, or intraoperative complications.
  • Outcomes & Predictors of Success:
    • Overall symptom improvement: 65–78% at 1 year (95% CI 60–84%), with highest efficacy in patients meeting strict diagnostic criteria (Choudhary et al., 2021 meta-analysis).
    • Favorable predictors:
      • Classic triad presence (OR 5.2, p<0.001)
      • 70% celiac stenosis on CTA
      • Positive diagnostic celiac plexus block
      • Absence of psychiatric comorbidity (depression/anxiety score <30 on HADS)
    • Poor response predictors:
      • Symptoms >5 years duration (chronic central sensitization)
      • Normal gastric emptying studies
      • Non-specific abdominal pain without weight loss
  • Recurrence & Reoperation: Rare (<10%); often due to incomplete ligament division or fibrosis. Re-laparoscopy can achieve 60–70%二次 success (Zhou et al., 2023).

Controversies and Emerging Concepts

  1. “MALS spectrum disorder”: Some patients exhibit compression without significant stenosis (<50%) but with neurogenic symptoms. The role of isolated plexus decompression remains debated.
  2. Association with EDS/HSD: Hypermobility Ehlers-Danlos Syndrome (hEDS/HSD) is overrepresented in MALS cohorts—ligamentous laxity may contribute to low PAL insertion and celiac trunk kinking (Tinkle et al., Am J Med Genet, 2021). Consider screening for hypermobility in refractory cases.
  3. Long-term GI motility recovery: Post-op gastric emptying often improves gradually over 6–12 months, but full resolution may not occur if central sensitization is established (Pimentel et al., Neurogastroenterol Motil, 2020).

Clinical Take-Home Messages for Providers

✅ Suspect MALS in thin patients with postprandial epigastric pain + weight loss unresponsive to standard care.
Always perform respiratory-gated imaging (CTA/MRA/US) — static studies miss dynamic compression in >30% of cases.
✅ Confirm diagnosis with a combination of anatomic (stenosis ≥70%) and functional (respiratory flow variation, delayed gastric emptying) criteria.
✅ Prioritize laparoscopic decompression over open surgery—lower morbidity, equivalent efficacy.
✅ Involve multidisciplinary teams: vascular surgery, gastroenterology, pain management, nutrition.

References (Key Recent Evidence)

  • Choudhary et al., Annals of Vascular Surgery (2021); 74: 539–546.
  • Cools et al., European Journal of Vascular and Endovascular Surgery (2018); 55(2): 196–203.
  • Zhou et al., JAMA Surgery (2023); 158(4): 321–330.
  • Liu et al., Pain Medicine (2022); 23(7): 1192–1200.
  • Tinkle et al., American Journal of Medical Genetics Part A (2021); 185(6): 1643–1650.

This review aligns with 2023 International Consensus Guidelines on Vascular Compression Syndromes (ICG-VCS).

Author

Leave a Reply